Artemis Medicare Services Ltd

₹ 78.2 3.10%
07 Dec - close price
artemishospitals.com BSE: 542919 NSE : ARTEMISMED
About

Artemis Medicare Services Ltd (AMSL) was incorporated on 2004, by the promoters of the Apollo Tyres Group, is engaged in healthcare business. AMSL operates a 318-bedded multi-specialty tertiary care hospital in Gurgaon. It has specialization in various segments like Orthopedics & Joint Replacement, Oncology, Cardiovascular, Neurosciences and Bariatric & Minimally Invasive Surgery. AMSL has been awarded with the NABH accreditation.

Key Points

Specialization-wise revenue break-up:
The revenue stream of AMSL remained well diversified in FY22.
1) Orthopaedics & Joint Replacement contributing (13%)
2) Oncology contributing (18%)
3) Cardiovascular contributing (10%)
4) Neuorologyeurosciences & some others together contributing( 17%)
5) Others incl. Medicine,Gynae,Nephrology etc (42%) [1]

Website BSE NSE
  • Market Cap ₹ 1,046 Cr.
  • Current Price ₹ 78.2
  • High / Low ₹ 83.0 / 33.8
  • Stock P/E 27.1
  • Book Value ₹ 28.7
  • Dividend Yield 0.00 %
  • ROCE 9.98 %
  • ROE 9.65 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Stock is trading at 2.73 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 3.49% over past five years.
  • Company has a low return on equity of 6.21% over last 3 years.
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
147.25 142.77 137.36 61.68 90.88 122.27 127.23 120.48 136.32 141.79 146.20 163.47 182.44
129.86 125.93 124.31 70.60 82.97 106.21 107.23 107.50 116.74 124.02 129.35 144.20 158.13
Operating Profit 17.39 16.84 13.05 -8.92 7.91 16.06 20.00 12.98 19.58 17.77 16.85 19.27 24.31
OPM % 11.81% 11.80% 9.50% -14.46% 8.70% 13.13% 15.72% 10.77% 14.36% 12.53% 11.53% 11.79% 13.32%
1.23 0.71 2.05 0.58 0.88 0.69 4.63 0.80 0.85 0.99 1.24 2.27 1.43
Interest 3.45 2.95 2.84 3.43 3.55 2.91 2.39 2.19 2.48 3.00 3.50 4.10 4.64
Depreciation 5.63 5.66 5.59 5.55 5.15 5.10 4.84 4.81 4.88 5.31 6.09 6.27 6.98
Profit before tax 9.54 8.94 6.67 -17.32 0.09 8.74 17.40 6.78 13.07 10.45 8.50 11.17 14.12
Tax % 38.78% 36.47% 32.83% 33.31% -288.89% 37.07% 26.49% 38.79% 35.96% 35.50% -56.82% 22.11% 30.59%
Net Profit 5.85 5.68 4.48 -11.55 0.35 5.49 12.79 4.16 8.36 6.73 13.32 8.70 9.80
EPS in Rs 0.28 0.43 0.34 -0.87 0.03 0.41 0.97 0.31 0.63 0.51 1.01 0.65 0.73
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
154 189 217 261 368 402 459 503 547 563 402 545 634
136 166 194 234 325 359 406 442 480 501 367 477 556
Operating Profit 18 23 23 27 43 43 53 60 66 62 35 68 78
OPM % 12% 12% 10% 11% 12% 11% 11% 12% 12% 11% 9% 12% 12%
3 2 2 1 3 5 4 3 2 4 7 3 6
Interest 16 16 15 13 12 9 9 9 11 13 12 11 15
Depreciation 9 9 9 9 12 12 15 18 20 22 21 21 25
Profit before tax -4 0 0 7 21 27 32 35 37 32 9 39 44
Tax % -0% 17% -0% -0% 12% 21% 16% 24% 44% 36% 20% 16%
Net Profit -4 0 0 7 19 22 27 27 21 20 7 33 39
EPS in Rs -0.20 0.01 0.02 0.32 0.88 1.03 1.29 1.27 0.98 1.54 0.54 2.46 2.90
Dividend Payout % -0% -0% -0% -0% -0% -0% -0% -0% -0% -0% -0% -0%
Compounded Sales Growth
10 Years: 11%
5 Years: 3%
3 Years: 0%
TTM: 25%
Compounded Profit Growth
10 Years: 65%
5 Years: 4%
3 Years: 15%
TTM: 33%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 128%
Return on Equity
10 Years: 8%
5 Years: 8%
3 Years: 6%
Last Year: 10%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
18 21 21 21 21 21 21 21 13 13 13 13 13
Reserves 69 109 109 116 135 163 183 210 280 301 308 348 369
166 121 118 110 85 68 94 91 114 108 137 190 220
31 33 39 66 90 93 124 130 160 159 130 145 187
Total Liabilities 284 284 287 313 331 345 422 452 555 581 589 697 790
243 239 237 236 239 249 283 309 381 387 372 476 531
CWIP -0 0 0 -0 0 1 27 43 49 56 81 64 60
Investments -0 -0 -0 -0 -0 -0 -0 -0 0 2 4 6 12
42 45 50 77 91 94 112 100 124 137 132 152 187
Total Assets 284 284 287 313 331 345 422 452 555 581 589 697 790

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
16 7 22 45 53 20 58 72 41 56 27 61
-0 4 -5 -12 -10 -14 -74 -67 -50 -22 -34 -106
-11 -13 -18 -21 -35 -24 19 -10 14 -33 13 44
Net Cash Flow 4 -3 -1 11 7 -18 3 -4 5 2 6 -2

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 33 45 40 41 39 49 48 40 52 50 48 47
Inventory Days 37 32 26 26 26 21 19
Days Payable 159 99 144 237 195 189 187
Cash Conversion Cycle -89 -22 -78 -171 -129 -120 -120 40 52 50 48 47
Working Capital Days -21 2 -9 -70 -59 -31 -44 -53 -26 -28 -15 -10
ROCE % 6% 6% 6% 8% 14% 15% 16% 15% 14% 11% 4% 10%

Shareholding Pattern

Numbers in percentages

Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
69.82 69.82 69.82 69.82 69.82 69.82 69.82 69.82 69.82 69.82 69.59 69.27
1.22 1.22 1.22 1.22 1.22 1.22 1.22 1.22 1.22 1.10 0.91 0.90
7.37 7.37 7.37 7.37 7.37 7.37 7.37 7.37 7.37 7.37 7.34 7.31
21.59 21.59 21.59 21.59 21.59 21.59 21.59 21.59 21.59 21.71 22.17 22.53

* The XBRL reporting format changed from Sep'2022 onwards. The new format added details about banks and foreign portfolio investors. These were not available earlier.
The sudden increase in FII or DII might be because of these changes.

Please click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls

  • Nov 2022
    Transcript
    PPT